Literature DB >> 3962778

Problems and results in testing the possible general mode of action of glucocorticoids in rat adjuvant arthritis.

R Hirschelmann, H Bekemeier.   

Abstract

The antiinflammatory action of dexamethasone in both phases of rat adjuvant arthritis was significantly reduced by injection of the RNA synthesis inhibitor actinomycin D into the inflamed paw. This effect is apparently caused by inhibition of RNA/protein synthesis and not by actinomycin D irritant activity. Thus, the present data support the view of indirect glucocorticoid activity via gene expression also in subacute and chronic adjuvant arthritis. The dexamethasone-induced antiinflammatory protein seems to be synthetized at the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3962778     DOI: 10.1007/bf01982636

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  4 in total

Review 1.  Vascular events in inflammation.

Authors:  G M Böhm
Journal:  Agents Actions Suppl       Date:  1977

2.  The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone.

Authors:  S Tsurufuji; K Sugio; F Takemasa
Journal:  Nature       Date:  1979-08-02       Impact factor: 49.962

3.  The influence of inhibitors of RNA and protein synthesis on dexamethasone action in carrageenin paw edema and adjuvant arthritis of rats.

Authors:  R Hirschelmann; R Schade; H Bekemeier
Journal:  Agents Actions Suppl       Date:  1982

4.  Problems and results in testing the possible mode of anti-inflammatory glucocorticoid action in carrageenin rat paw oedema: advantages of local substance injection.

Authors:  R Hirschelmann; H Bekemeier
Journal:  Int J Tissue React       Date:  1984
  4 in total
  1 in total

1.  Effects of dexamethasone and acetylsalicylic acid on inflammation caused by Complete Freund's adjuvant in the naked mole rat (Heterocephalus glaber).

Authors:  J K N Thuo; P K Towett; T I Kanui; K S P Abelson
Journal:  Heliyon       Date:  2022-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.